More than 2 in 5 Americans with diabetes have some stage of diabetic retinopathy¹
Patients may not have any symptoms in the early stages of the disease¹
95% of vision loss can be prevented with early detection²
How it Works
Note: Not all products shown on this site are offered in every market. Product features may vary by country and are subject to change. For products specific to your area, please visit the website appropriate to your country or contact Topcon Healthcare for more information.
Learn more about Topcon Screen
Implementing Topcon Screen as point-of-care testing for diabetic retinopathy allows primary care physicians to reach more patients and improve care coordination for your diabetic patients diagnosed with a vision pathology.